Back to search
Sickle Red Blood Cell
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sickle Red Blood Cell trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Sickle Red Blood Cell trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
A phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or w…
The purpose of this study is to collect and store samples and health information for current and future research to learn more about the causes and treatment of…
Background: Some people with the same disorder on a genetic level have more complications than others. Researchers want to look for a link between the PKLR gen…
This study will collect representative blood samples from healthy children and adults and from children and adults who have unique red blood cell features that…
A single center, open label, interventional, phase II trial for donor transplant for high risk hemoglobinopathies and other red cell transfusion dependent disor…
The purpose of this research study is to look at genes and determine how they interact with each other to find changes that could explain why some people's immu…
Erythrocyte morphology analysis is a key step in the diagnosis flowchart of anemia. It is performed on a peripheral blood smear after May Grümwald Giemsa staini…
The purpose of this study is to compare the efficacy and safety of 2 doses of crizanlizumab (5.0 mg/kg and 7.5 mg/kg) versus placebo in adolescent and adult sic…